INTRODUCTION:

Bioanalysis is the system used to determine the attention of medicines, their metabolites and/ or endogenous substances in the natural matrices similar as blood, plasma, serum, cerebrospinal fluid, urine, and slaver.

The system includes collection, processing, storehouse and analysis of a natural matrix for a medicine (chemical emulsion). High performance liquid chromatography (HPLC) analysis is useful in identification and quantitative determination of medicines and metabolites in natural fluids, particularly tube, serum or urine. HPLC requires good selections of sensors, good stationary phase, eluents and acceptable program during separation. UV/ VIS sensor is the most protean sensor used in HPLC. UV discovery is preferred as it provides excellent linearity and rapid-fire quantitative analysis against a single standard of the medicine being determined. The review focuses on bioanalytical system development using High performance liquid chromatography (HPLC) and including effective sample medication. Both RP- HPLC and LCMS- MS can be used for the bioanalysis of medicines in tube. Each of the instruments has its own graces. RP- HPLC coupled with UV, PDA or luminescence sensor can be used for estimation of numerous composites. The main advantages of these chromatographic principles includes low discovery limits, the capability to induce structural information, the demand of minimum sample treatment and the possibility to cover a wide range of analytes differing in their oppositeness. Bioanalytical styles are extensively used to quantitative medicines and their metabolites in the physiological matrices and the styles could be applied to studies in areas of mortal clinical pharmacology and non mortal pharmacology/ toxicology. Bioanalytical system employed for the quantitative determination of medicines and their metabolites in natural fluids plays a significant part in the evaluation and interpretation of bioequivalence, pharmacokinetics and poisonous kinetic studies. It helps in carrying studies like pharmacodynamics, toxicology, pharmacokinetics, bioequivalence, remedial medicine monitoring (TDM) and clinical studies. Original stages these studies are done only to find out over lozenge conditions and in toxicological studies. When attention of medicine in natural matrix is known, also pharmacokinetic parameters are calculated from that. Bioanalytical studies are important in medicine discovery and development. So these studies are performed precisely.

MATERIALS AND METHODS:

Biological matrices relevant in bioanalysis:

In bioanalytical studies, colorful types of natural matrices (e.g., blood, plasma, serum, urine, hair, mortal bone milk, slaver, sweat, cerebrospinal fluid (CSF), and towel) need to be delved. In addition, every matrix has unique challenges. For illustration, tube contains further phospholipids, whereas urine contains a large quantum of swab. Conventionally, biofluids (e.g., blood, serum, plasma, saliva, sweat, urine, and Tissue) are used considerably in bioanalysis¹. Lately, hair, Human Breast milk, and feces have also been used as natural samples. Hair is a stable and tough matrix that's easy to handle and hardly tampered with during collection, and it has a high degree of declination in posthumous studies. Human Breast milk is an excellent marker of medicines and ecological adulterants. As has been known for a long time, medicine and metabolite excretion in bone milk is a pivotal issue for suckling maters. Analogous to excretion in bone milk, some herbal drugs may be metabolized by intestinal micro biota and excreted in feces. Feces are non digested, non homogeneous, complex, and laden with macromolecules and particulates, which can present problems for logical systems. Global metabolic monitoring of feces demonstrates a challenge from both biochemical and logical slants. A short preface to natural samples is handed below².

Blood, plasma, and serum:

Blood is composed of colorful blood cells suspended in plasma. Plasma is composed of roughly 55 % of blood ﬂuid in humans and constitutes glucose, proteins, hormones, minerals, and blood cells. Serum is the fluid and solute element of blood without fibrinogens. It contains a variety of metabolites that can be used in the opinion of varied clinical conditions and numerous severe diseases³.

Urine:

Urine is overwhelmingly composed of water( i.e., 95), in addition to inorganic salts(e.g., sodium, phosphate, sulfate, and ammonia), urea, creatinine, proteins, and pigmented products of blood breakdown(e.g., urochrome). Urinary metabolomics approaches are likely to be used to cover previous individual and prognostic biomarkers of diseases similar as urinary tract infection and chronic kidney disorders⁴.

Hair:

Hair is a hard and strong tissue. It's considerably used in bioanalysis due to its ideal properties. Hair is a stable and strong matrix that's non-invasively collected, easy to handle and transport, and hardly tampered with during collection. In the case of medicine addicts, utmost medicines are set up in hair. Hair analysis is also used to give DNA evidence for criminal cases and disquisition of heavy metals in the body, similar as arsenic, mercury, and lead^5,6.

Human breast milk:

Human breast milk is composed of certain situations of fat, proteins, lactose, and minerals. It's an excellent biomarker for the discovery of medicines, metabolites, and environmental adulterants. Some medicines and metabolisms are excreted in breast milk, with lipophilic medicines having a advanced tendency to excrete into breast milk, which can present a serious problem for breastfeeding mothers and the threat of babies entering excreted medicines and metabolites. Thus, it's judicious to cautiously feed maters on any medicinal treatment during breastfeeding. Breast milk can be collected in a clinically commended pump with glass vessels. The collected samples were transferred to polypropylene tubes for analysis. The collected samples were transferred to polypropylene tubes for analysis⁷.

Saliva:

Saliva is composed of nearly 99 of water and composites secreted by the salivary glands. Due to its easy collection and presence of significant biomarkers in numerous severe diseases, saliva has come a preferable natural fluid. Saliva contains a variety of electrolytes, including sodium, potassium, bicarbonate, magnesium, phosphate, and calcium. Saliva is an absolute medium that can be covered for the examination of numerous diseases. In addition, saliva comprises a number of cytokines, enzymes, hormones, and antimicrobial factors. Several biomarkers of heart conditions and cancers can be set up in saliva. Saliva has been used as a individual aid in clinical situations similar as cystic fibrosis, Sjogren's syndrome, and adrenal cortex- related diseases. Compared to other natural fluids, slaver collection and running is accessible, noninvasive, and provident⁸.

Sweat and skin surface lipids:

Sweat is comprised of roughly 99 water and sodium chloride as the main solute. Skin surface lipids comprise a mixture of sebum and keratinocyte membrane lipids.Lipophilic medicines are prone to excretion through passive diffusion into sweat glands. Hence, it's important to be attentive to skin surface lipids and sweat samples. Clinically, sweat is the gold standard for the diagnosis of cystic fibrosis and numerous other severe diseases⁹.

Feces:

Fecal matter as human body waste generally consists of inedible food matter, inorganic substances (e.g., calcium and iron phosphate), and certain quantities of dead bacteria. Some drugs may be metabolized by intestinal micro flora and excreted in the feces. The fecal sample is an ideal instance for the disquisition of herbal drugs metabolized by the intestinal micro biota. Generally, before testing the fecal matter, the person is supposed to be fasting. The fecal samples are also collected and placed in normal saline until farther processing. Clinically, fecal analysis is primarily performed to identify conditions of the digestive tract, liver, and pancreas¹⁰.

Tissue:

Tissues are composed of a group of cells with analogous functions and shapes. They can be distributed into three sections soft tissues, tough tissues, and hard tissues. Soft tissues (e.g., lung, liver, kidney, brain, and spleen) are simple to manage. Tough tissues (e.g., stomach, intestine, colon, muscle, placenta, heart, and artery) bear applicable approaches. Quantiﬁcation of cures in the skin is querying due to low quantities that may be present, small sample amounts, and the rigid nature of skin itself. Hard tissues (e.g., cartilage, cadaverous muscle, nail, bones, and hair) suffer a typical defined process in terms of collection. Hence, all tissues bear accurate sample medication before pacing to analysis. Tissues play crucial places in clinical diagnostic purposes, similar as tumor and cancer discovery¹¹.

CSF:

CSF is the secretion fluid of the central nervous system (CNS), and roughly 80% is produced by the choroid plexus that occupies the ventricles of the brain, subarachnoid space, and spinal cord. Proper and accurate study of the CSF metabolism can oﬀer numerous clinically important perceptivity into critical CNS affections (e.g., Parkinson's disorder, multiple sclerosis, brain injury, and Guillain- Barre syndrome)¹².

METHOD DEVELOPMENT:

The process of developing an analytical technique enables a compound of interest to be located and measured in a matrix. Drug development requires a method development process that is well organised. Sample preparation, analyte separation, analyte detection, and evaluation of the results are the three essential interconnected components of method creation.

Sample collection and preparation:

In general, biological fluids like blood, plasma, urine, and serum contain the analyte. Blood is usually collected from human patients by vein puncturing with a hypodermic syringe that holds 5 to 7 ml. (depending on the assay sensitivity and the total number of samples taken for a study being performed). Blood from the veins is drawn out and placed in tubes with an anticoagulant, such as EDTA, heparin, etc. Centrifugation at 4000 rpm for 15 minutes yields plasma. About 30 % to 50 % of the volume is collected. The objective of sample preparation is to concentrate the sample and clean it up before analysis. Proteins, salts, endogenous macromolecules, small molecules, and metabolic residues are examples of substances present in biological samples that can interfere with analysis or cause the chromatographic column or detector to malfunction. As part of the sample preparation process, the analyte from the biological matrix is also exchanged for a solvent that can be used to inject it into the chromatographic instrument. General sample preparation techniques include protein precipitation, solid-phase extraction (SPE), and liquid/liquid extraction¹³.

Biological matrices used in bioanalysis:

Determination of drug in urine is an indirect method to ascertain the bioavailability of a drug. Estimation of drug in feces may reflect drug that has not been absorbed after an oral dose or may reflect drug that has been expelled by biliary secretion after systemic absorption. Salivary drug levels indicate free drug rather than total plasma drug concentration as only free drug diffuses into the saliva. Therefore, the saliva/plasma drug concentration ratio is less than 1 for many occasions. Measurement of a drug concentration in the blood, serum or plasma is the most direct approach to assess the Pharmacokinetics of the drug in the body. Assuming that a drug in the plasma is in dynamic equilibrium with the tissues, and then changes in the drug concentration in plasma will reflect changes in tissue drug concentrations¹⁴.

Preservation of Biological Samples:

Biological fluids are highly susceptible to physicochemical changes as they contain different substances. Processing or purifying biological samples is often time consuming therefore optimal storage conditions must be established for biological samples. Samples sensitive to oxidation can be protected by using air tight containers. Dehydration of moisture sensitive drugs could be achieved largely by freeze-drying or lyophilisation¹⁵.

Sample Pretreatment:

Pretreatment of serum and plasma samples is not necessary if the analyte is protein-bound. In such cases, one of the following methods can be followed.

Using 0.1M or greater concentration of acids or bases make the pH of the sample to pH<3

• Using 0.1M or greater concentration of acids or bases make the pH of the sample to pH<3or pH>9. Separate the resulting supernatant and use it as the sample for extraction.

• Precipitate the proteins from biological fluid with a polar solvent such as acetonitrile, methanol or acetone in 1:2 ratio by centrifugation, and use the supernatant for the extraction¹⁶.

Treat the biological fluid with acids or inorganic salts, such as formic acid, perchloric acid, trichloroacetic acid, ammonium sulfate, sodium sulfate, or zinc sulfate to precipitate proteins. Adjust the pH of the resulting supernatant, sonicate for 15 minutes, dilute with water or buffer, centrifuge, and use the supernatant for the extraction¹⁷.If the analyte is not protein bound, the pre-treatment methods include centrifugation, homogenization and hydrolysis of conjugates. Centrifugation is the process of separating cells from serum and plasma. Centrifugation of biological fluid is usually done by using cooling centrifuge at 4^oCto avoid decomposition of the analyte and the clear supernatant liquid is used for analysis.For samples containing insoluble proteins, such as muscle or other related tissues, a homogenization or solubilizing step, using 1N hydrochloric acid, may be required before treating the sample further. A solid sample such as faeces can be homogenized with a minimum amount of methanol with a blade homogenizer or tissue homogenizer^18,19.

Separation of analyte:

Extraction procedures for drugs and metabolites from biological samples Extraction of analyte from biological matrix is traditionally carried out by (a) liquid-liquid extraction (LLE), (b) solid-phase extraction (SPE) and (c) precipitation of plasma proteins (PP)²⁰

Liquid – Liquid extraction:

It is based on the principles of differential solubility and partitioning equilibrium of analyte molecules between aqueous (the original sample) and the organic phases. Liquid – Liquid extraction generally involves the extraction of a substance from one liquid phase to another liquid phase. Now a day’s traditional LLE has been replaced with advanced and improved techniques like liquid phase micro extraction, single drop liquid phase micro extraction and supported membrane extraction. Separation of analyte occurs based on its partition coefficient between two immiscible liquids and extraction can be done by using a suitable solvent. LLE method is simple, rapid, and relatively cost effective compared to other techniques. Most of the drugs can be recovered to the extent of 90% by multiple continuous extraction technique²¹.

First, dissolve the component mixture in a suitable solvent and then add an immiscible solvent with the first solvent. Mix the contents thoroughly and set a side to separate the two immiscible solvents into layers. The components of the mixture will be distributed amongst the two immiscible solvents based on their partition coefficients. Separate the two immiscible solvent layers, transfer and isolate the component from each solvent. After extraction hydrophilic compounds get in the aqueous phase and hydrophobic compounds are found in the organic solvents. Non polar analytes extracted into the organic phase can be easily recovered by evaporation of the solvent, the residue reconstituted with a small. volume of an appropriate solvent preferably mobile phase. Polar analytes extracted in to the aqueous phase can be directly injected into a reverse phase (RP) column²².

Sometimes the method requires pH control of samples for extraction. The method is not suitable for thermolabile substances as high temperature is used during evaporation.

Solid Phase Extraction (SPE): Solid phase extraction is a method for specifically eluting analytes from samples after they have been bound to a solid support and interferences have been eliminated. Solid phase extraction is a powerful technique due to there are so many different sorbent options. Conditioning, sample loading, washing, and elution are the four stages in the solid phase.

SPE is a common effective method for isolating and concentration of analyte in trace quantities in a variety of sample matrices. SPE makes it possible to minimise final sample volume and level of interference while increasing analyte sensitivity. A small plastic disposable column or cartridge containing 0.1 to 0.5 g of sorbent, which is typically RP material (C18 or C8) can be used to obtain higher analyte recovery. Depending on their choice, the components of interest may either preferentially adsorb to a solid or remain in the liquid phase.If the desired analyte is adsorbed on the solid phase, washing with a suitable solvent will preferentially remove it. Concentration, evaporation, or recrystallization can be used to recover an important component that is still in a liquid phase. SPE extraction requires more time, and it can be difficult to separate high density materials²³.

Steps in the extraction of the analyte from plasma by SPE:

a) Pretreatment of sample: which includes dilution of sample or pH adjustment, filtration to avoid the blocking of the SPE cartridge and for better adsorption.

b) Conditioning of the cartridge - It is the main step in case of reverse phase SPE cartridges. Preconditioning of the cartridge is necessary to obtain reproducible results and is done by solvents such as methanol, acetonitrile, isopropyl alcohol or tetrahydrofuran. Otherwise, a highly aqueous solvent cannot penetrate the pores and wet the surface. As a result only limited fraction of the surface is available for interaction with the analyte. So it is important to maintain wet ness of the cartridge up to sample loading.

c) Loading the sample - The sample size must be adjusted to suit the cartridge bed. A typical RP cartridge can hold up to 100 mg of substances that are very strongly retained.

d) Washing the SPE bed- A suitable solvent or water mixture is passed through SPE bed to remove the contaminants.

e) Elution of fraction - A suitable solvent or buffer is used to elute the analyte from the SPE bed for analysis²⁴.

(c) Protein precipitation (PP): Protein precipitation is a very simple technique for extraction of the analyte from blood or plasma. The main requirement for this technique is that the analyte should be freely soluble into reconstituting solvent²⁵. In this technique, the sample is prepared by protein precipitation by using acids (trichloroacetic acid and perchloric acid)/ organic solvents (methanol, ethanol, acetone and acetonitrile) or salts (ammonium sulphate). After precipitation the sample is centrifuged, analyte gets into supernatant. Among the solvents methanol is preferred as it produces clear supernatant which is suitable for direct injection. PP can be employed for extraction of hydrophilic and hydrophobic substances. The limitation is PP may clog the column²⁶.

Salting out with Ammonium sulphate:

Ammonium sulphate is used for salting out, because of its high solubility and high ionic strength. Its solubility changes little with temperature and is cheap. The density of a concentrated solution is less than that of protein, so that protein can be easily centrifuged from the concentrated solutions²⁷.

Solvent Precipitation:

Proteins precipitate when significant quantities of a water-miscible solvent, like ethanol or acetone, are added to a protein solution. This is because the dielectric constant is dropping, which would result in greater interactions between charged groups on the surface of proteins. As proteins tend to denature at higher temperatures, solvent precipitation for the protein is carried out at 0°C and the solvent colder, -20°C in an ice-salt bath²⁸.

Detection of analyte:

HPLC Instrumentation:

In biochemistry and analysis, high-performance liquid chromatography (HPLC) is used to isolate, identify, and quantify the active compounds. A pump, injector, column, detector, integrator, and display system constitute HPLC instrumentation. The column where separation takes place is the heart of the system. A high pressure pump is required to transport the mobile phase through the column since the stationary phase is made up of porous micron-sized particles. A small volume of the sample to be examined is added to the stream of mobile phase. The retention times for the molecules are displayed by the detector. The retention time is the amount of time required for a particular substance to elute, or exit the column²⁹.

Injection of the sample:

Sample solution can be injected by using septum injectors, when the mobile phase is flowing or it is stopped. A new advanced rotary valve and loop injector can be used to produce reproducible result

Conditioning:

The column is activated with an organic solvent that acts as a wetting agent on the packing material and solvates the functional groups of the sorbent. Water or aqueous buffer is added to activate the column for proper adsorption mechanisms.

Sample Loading:

The sample is loaded onto the column by gravity feed, pumping, or aspirating by vacuum after the pH has been adjusted.

Washing:

The analyte is retained while matrix interferences are eliminated.

Elution:

A suitable solvent is used to distribute the analyte-sorbent interactions while removing as little interferences as feasible.

Typically, sorbents used in SPE consists of 40 μm diameter silica gel with approximately 60 A0 pore diameters. Functional groups are chemically attached to this silica gel for various modes of action. The most popular configuration is a syringe barrel, also known as a packed column, that has a 20 μm frit at the bottom of the syringe with the sorbent material and another frit on top. Extractions disks are placed in syringe barrels. The packing material used to make these disks is composed of 8–12 μm particles that are embedded in an inert matrix. Similar to stacked columns, disks are used and condition in the same manner. The ability to use greater flow rates is disks main advantage over packed columns. Analytes can be divided into four groups: amphoteric, basic, acidic, and neutral compounds. Amphoteric analytes can act as cations, anions, or zwitterions based on the pH since they have both basic and acid functional groups³⁰.

CONCLUSION:

The generation of pharmacokinetic, toxicokinetic, and metabolic data through bioanalysis is essential to pharmaceutical research and development activities engaged in the process of drug discovery and development. The relatively new ideas and recent advancements in several areas, such as sample preparation, separation, how to minimize the matrix effect, and specific recommendations for bioanalytical methods discussed in this review, attest to the use of RP-HPLC as the preferred method for bioanalysis of small molecules. The novel concepts and suggestions outlined can be utilized to enhance the development of RP-HPLC bioanalytical method and the matrix effect caused due to the presence of undesired analytes or other interfering substances in the sample. With the advent modern instruments and novel biological matrix purification techniques, it has become common to modify current bioanalytical method development. The information produced by a developed, well-documented bioanalytical method is useful in enhancing existing bioanalytical methods. Improvement of bioanalytical techniques using HPLC to obtain drug pharmacokinetic and toxicokinetic data more quickly. The development of bioanalytical method is helpful in determining the identity, purity, potency, and bioavailability of drugs. Therefore, the creation of bioanalytical HPLC method is essential for determining a drug concentration in bulk and in pharmaceutical dosage forms as well as for monitoring and controlling impurities in drugs.

CONFLICT OF INTEREST:

The authors have no conflicts of interest regarding this investigation.

REFERENCES:

1. Sharma, Shivani and Singh, Navdeep and Ankalgi, Amar and Rana, Arti and Ashawat, Mahendra. Modern Trends in Analytical Techniques for Method Development and Validation of Pharmaceuticals: A Review. Journal of Drug Delivery and Therapeutics. 2021; 11:121- 130. 10.22270/jddt.v11i1-s.4515.

2. A. Kirthi, R. Shanmugam, M. Shanti Prathyusha, D. Jamal Basha: A Review on bioanalytical method development and validation by RP–HPLC. 2014; 5(4): 2265-2271 (https://www.jgtps.com/admin/uploads/apjI6Z.pdf)

3. Pushpa Latha et al. Bioanalytical Methodm Development and Validation by HPLC A Review. Journal of Medical and Pharmaceutical Innovation. 2014; 1(6S): 1-9 (https://www.researchgate.net/publication/352834227_)

4. A Review On Bioanalytical Method Development and_Validation BY RP-HPLC (https://www.researchgate.net/publication/355939319)

5. Recent advances in sample preparation techniques for effective bioanalytical methods (https://www.researchgate.net/publication/49680400)

6. A Review on Analytical Method Development and Validation of Pharmaceutical Technology (https://www.pharmatutor.org/articles)

7. Sample Preparation in Bioanalysis: A Review (https://www.pharmatutor.org/articles/)

8. A review of current bioanalytical approaches in sample pretreatment techniques for the determination of antidepressants in biological specimens. Sofia Soares, Mário Barroso and Eugenia Gallardo From the Journal Reviews in Analytical Chemistry (https://doi.org/10.1515/revac-2021-0124)

9. Recent advances in sample preparation techniques for effective bioanalytical methods Prashant Laxman Kole 1, Gantala Venkatesh, Jignesh Kotecha, Ravi Sheshala (https://pubmed.ncbi.nlm.nih.gov/21154887/)

10. Bioanalytical Analysis of Small-Molecule Drugs and Metabolites in Physiological Samples by LC–MS, Part 2: Sample Preparation Published on: August 1, 2021 Stephanie J. Marin, Jeremy Smith, Jillian Neifeld, Elena Gairloch LCGC North America, August 2021, Volume 39, Issue 8 Pages: 372–383

11. Review ArticleRecent advances in sample preparation techniques for effective bioanalytical methods Volume25, Issue1-2 Special Issue: Silver Jubilee Special Issue and amp; Special Reviews Issue: Bioanalysis of Drugs and Metabolites January ‐ February 201: 199-217 (https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bmc.1560)

12. A Review on Analytical Method Development and Validation by High Performance Liquid Chromatography Technique Siddhata Deshmukh, Ganesh Chavan (https://www.jpsr.pharmainfo.in/Documents/Volumes/vol11issue11/jpsr11111910.pdf)

13. HPLC Method Development and Validation: A Review October 2015 International Research Journal of Pharmacy (https://www.researchgate.net/publication/283759781_)

14. Extraction and Sample Preparation Mohammad Rezaee (https://www.hindawi.com/journals/ijac/2015/397275)

15. HPLC method development- A Review. Pallavi Nemgonda Patil (https://www.gyanvihar.org/researchjournals/pjournals2017/4.Pallavi.pdf)

16. Advances in sample preparation and HPLC–MS/MS methods for determining amyloid-β peptide in biological samples: a review Israel Donizeti de Souza and Maria Eugênia Costa Queiroz

17. Bioanalytical method development models and validation for drug and its metabolite by using LCMS/MS: A Review Journal of Pharmacy Research, 2012.

18. A review of modern sample-preparation techniques for the extraction and analysis of medicinal plants Carmen W Huie (https://pubmed.ncbi.nlm.nih.gov/12012169/)

19. Innovative Configurations of Sample Preparation Techniques Applied in Bioanalytical Chemistry: A Review February2019CurrentAnalyticalChemistry (https://www.researchgate.net/publication/331319283)

20. Applied in Bioanalytical Chemistry A Review) Bioanalysis: methods, techniques, and applications Author links open overlay panel Mithun Rudrapal 1, Aniket P. Kothawade (https://www.sciencedirect.com/science/article/pii/B9780128226544000026)

21. Current developments of bioanalytical sample preparation techniques in pharmaceuticals Author links open overlay panel Rahul G. Ingle, Su Zeng, Huidi Jiang, Wei-Jie Fang, Samanidou, Ioannis Papadoyannis (https://betasciencepress-publishing.com/10-17145/fulltext/jab/

22. Sharma, Shivani and Singh, Navdeep and Ankalgi, Amar and Rana, Arti and Ashawat, Mahendra.. Modern Trends in Analytical Techniques for Method Development and Validation of Pharmaceuticals: A Review. Journal of Drug Delivery and Therapeutics. 2021; 11: 121-130. 10.22270/jddt.v11i1-s.4515.

23. Kachave, Ramanlal and Mundhe, Akshay. Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC. European Pharmaceutical Journal. 2022; 68:. 49-58. 10.2478/afpuc-2021-0019.

24. Amruta S. Kadam, Nayana V. Pimpodkar, Puja S. Gaikwad, Sushila D. Chavan. Bioanalytical Method Validation. Asian J. Pharm. Ana. 2015; 5(4): 219-225.

25. Paras Virani, Rajanit Sojitra, Hasumati Raj, Vineet Jain. Atorvastatin: A Review on Analytical Method and Its Determination in Pharmaceuticals and Biological Matrix. Asian J. Pharm. Ana. 2015; 5(3): 151-160. doi: 10.5958/2231-5675.2015.00025.3

26. Punam S. Desai, Rajeshwar V. Chavan, Nikita B. Amane, Sanmati D. Shete, Archana R. Dhole. High Performance Liquid Chromatography – A Validation View.Asian J. Pharm. Ana. 2019; 9(4): 232-236.

27. R. B. Saudagar, P. G. Thete. Bioanalytical Method Validation: A Concise Review. Asian J. Res. Pharm. Sci. 2018; 8(2):107-114.

28. Harshita H. Patel, Vishwas C. Bhagat, Rajkumar V. Shete, Amit S. Ravetkar. Analytical Method Development and Validation for biotin from Premixes (solid blend of Multi-Vitamin) by RP-HPLC. Research J. Pharm. and Tech. 2020; 13(3):1314-1318.

29. Vyshali Veerareddy, and Kumaraswamy Gandla. A Review On Bioanalytical Method Development and Validation by Hyphenated Techniques. Journal of Pharmaceutical Negative Results. 2022; 35–40. https://doi.org/10.47750/pnr.2022.13.S01.05

30. Seema R. Nikam, Amol S. Jagdale, Sahebrao S. Boraste, Shrikant B. Patil. Bioanalysis - Method Development, Validation, Sample Preparation, its Detection Techniques and its Application. Asian Journal of Pharmaceutical Analysis. 2021; 11(4): 297-5. doi: 10.52711/2231-5675.2021.00051

Received on 11.04.2023 Modified on 25.10.2023

Asian J. Pharm. Ana. 2024; 14(2):109-115.

DOI: 10.52711/2231-5675.2024.00019